Xylem (XYL) to Release Quarterly Earnings on Tuesday

Xylem (NYSE:XYL) is anticipated to announce its Q3 2025 results before the market opens on Tuesday, October 28th. Analysts expect the company to announce earnings of $1.24 per share and revenue of $2.22 billion for the quarter. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS.Investors may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Tuesday, October 28, 2025 at 9:00 AM ET.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to analysts’ expectations of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.09 EPS. On average, analysts expect Xylem to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Xylem Stock Performance

NYSE:XYL opened at $148.31 on Monday. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $36.10 billion, a price-to-earnings ratio of 38.52, a PEG ratio of 2.53 and a beta of 1.13. The firm’s fifty day simple moving average is $143.79 and its 200 day simple moving average is $132.92. Xylem has a twelve month low of $100.47 and a twelve month high of $151.16.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were issued a dividend of $0.40 per share. The ex-dividend date was Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem’s payout ratio is presently 41.56%.

Analysts Set New Price Targets

Several research firms recently weighed in on XYL. Barclays began coverage on shares of Xylem in a report on Friday, September 19th. They set an “overweight” rating and a $165.00 target price on the stock. UBS Group lifted their target price on shares of Xylem from $164.00 to $168.00 and gave the company a “buy” rating in a report on Tuesday, August 5th. Cowen restated a “hold” rating on shares of Xylem in a report on Tuesday, August 26th. Zacks Research upgraded shares of Xylem from a “hold” rating to a “strong-buy” rating in a report on Monday, September 22nd. Finally, Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $154.67.

Insider Activity at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the transaction, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.27% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. FWL Investment Management LLC acquired a new position in shares of Xylem during the 2nd quarter worth $43,000. State of Wyoming bought a new stake in shares of Xylem during the 2nd quarter worth $89,000. MUFG Securities EMEA plc bought a new stake in shares of Xylem during the 2nd quarter worth $93,000. EverSource Wealth Advisors LLC boosted its holdings in shares of Xylem by 114.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock worth $154,000 after buying an additional 635 shares during the period. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of Xylem by 13,322.2% during the 2nd quarter. Geneos Wealth Management Inc. now owns 1,208 shares of the industrial products company’s stock worth $156,000 after buying an additional 1,199 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.